{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:48:48Z","timestamp":1791265728711,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.semcdb.2017.12.017","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T14:31:59Z","timestamp":1515767519000},"page":"86-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Complement as a diagnostic tool in immunopathology"],"prefix":"10.1016","volume":"85","author":[{"given":"Alberto","family":"L\u00f3pez-Lera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Corvillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Nozal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"S\u00e1nchez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"L\u00f3pez-Trascasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0005","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.molimm.2003.10.009","article-title":"Evolution of the complement system","volume":"40","author":"Nonaka","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.00001","article-title":"Keeping it all going-complement meets metabolism","volume":"8","author":"Kolev","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2016.11.011","article-title":"Complement in basic processes of the cell","volume":"84","author":"Jim\u00e9nez-Reinoso","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2017.05.012","article-title":"Intracellular complement-the complosome\u2013in immune cell regulation","volume":"89","author":"Arbore","year":"2017","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.semcdb.2017.12.017_bib0030","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.semcdb.2017.12.017_bib0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol. Rev."},{"issue":"October (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molimm.2014.06.030","article-title":"Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach","volume":"61","author":"Grumach","year":"2014","journal-title":"Mol. Immunol."},{"issue":"July (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2016.00055","article-title":"Systemic lupus erythematosus and deficiencies of early components of the complement classical pathw","volume":"7","author":"Macedo","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.semcdb.2017.12.017_bib0055","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jaci.2015.08.017","article-title":"Clinical characteristics and genotype-phenotype correlations in C3 deficiency","volume":"137","author":"Okura","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"October (7)","key":"10.1016\/j.semcdb.2017.12.017_bib0060","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.4049\/jimmunol.181.7.5158","article-title":"Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells","volume":"181","author":"Ghannam","year":"2008","journal-title":"J. Immunol."},{"issue":"March (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/eji.201444948","article-title":"Dysregulation of adaptive immune responses in complement C3-deficient patients","volume":"45","author":"Pekkarinen","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"March (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-3083.2006.01729.x","article-title":"Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H","volume":"63","author":"Reis","year":"2006","journal-title":"Scand. J. Immunol."},{"issue":"October (17)","key":"10.1016\/j.semcdb.2017.12.017_bib0075","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMc1306326","article-title":"Deficiency in complement factor B","volume":"369","author":"Slade","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"November (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2249.1999.01057.x","article-title":"Properdin deficiency and meningococcal disease--identifying those most at risk","volume":"118","author":"Linton","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"June (12)","key":"10.1016\/j.semcdb.2017.12.017_bib0085","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1182\/blood-2005-07-2820","article-title":"Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections","volume":"107","author":"Sprong","year":"2006","journal-title":"Blood"},{"issue":"December (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0090","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1998.00738.x","article-title":"Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine","volume":"114","author":"Fijen","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"August (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/sji.12070","article-title":"Humoral pattern recognition and the complement system","volume":"78","author":"Degn","year":"2013","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.semcdb.2017.12.017_bib0100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.177.1.722","article-title":"Homozygosity for the IgG2 subclass allotype G2M(n) protects against severe infection in hereditary C2 deficiency","volume":"177","author":"J\u00f6nsson","year":"2006","journal-title":"J. Immunol."},{"issue":"August (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0171-2985(98)80037-5","article-title":"Mannose-binding lectin (MBL) in health and disease","volume":"199","author":"Turner","year":"1998","journal-title":"Immunobiology"},{"issue":"August (14)","key":"10.1016\/j.semcdb.2017.12.017_bib0110","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.molimm.2011.05.001","article-title":"Complement deficiency states and associated infections","volume":"48","author":"Skattum","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajhg.2010.09.018","article-title":"MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes","volume":"87","author":"Sirmaci","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"December (6)","key":"10.1016\/j.semcdb.2017.12.017_bib0120","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jaci.2006.08.004","article-title":"Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency","volume":"118","author":"Garc\u00eda-Laorden","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"June (25)","key":"10.1016\/j.semcdb.2017.12.017_bib0125","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1056\/NEJMoa0900381","article-title":"Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency","volume":"360","author":"Munthe-Fog","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0130","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.semcdb.2017.12.017_bib0135","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"July (2\u20133)","key":"10.1016\/j.semcdb.2017.12.017_bib0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","article-title":"Complement and autoimmunity","volume":"56","author":"Ballanti","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-016-1123-x","article-title":"The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis","volume":"18","author":"Struglics","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"May (5)","key":"10.1016\/j.semcdb.2017.12.017_bib0150","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"HAWK under the patronage of EAACI (European Academy of Allergy and Clinical Immunology). Classification, diagnosis, and approach to treatment for Angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"issue":"June (9117)","key":"10.1016\/j.semcdb.2017.12.017_bib0155","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"issue":"June (6)","key":"10.1016\/j.semcdb.2017.12.017_bib0160","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.jaci.2013.12.1072","article-title":"Endothelial cell activation during edematous attacks of hereditary angioedema types I and II","volume":"133","author":"Kajd\u00e1csi","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"April (1)","key":"10.1016\/j.semcdb.2017.12.017_bib0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cei.12910","article-title":"Comparing acquired angioedema with hereditary angioedema (types I\/II): findings from the Icatibant Outcome Survey","volume":"188","author":"Longhurst","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"18","key":"10.1016\/j.semcdb.2017.12.017_bib0170","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.semcdb.2017.12.017_bib0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2014-03-560540","article-title":"Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"125","author":"Peffault de Latour","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semcdb.2017.12.017_bib0180","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.it.2015.04.008","article-title":"Factor H-related proteins determine complement-activating surfaces","volume":"36","author":"J\u00f3zsi","year":"2015","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.semcdb.2017.12.017_bib0185","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"French Study Group for aHUS\/C3G. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"issue":"14","key":"10.1016\/j.semcdb.2017.12.017_bib0190","first-page":"1379","article-title":"Eculizumab in atypical hemolytic-uremic syndrome","volume":"369","author":"Legendre","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.semcdb.2017.12.017_bib0195","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"September (1)","key":"10.1016\/j.semcdb.2017.12.017_bib0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.semcdb.2017.12.017_bib0205","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.1402770","article-title":"Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases","volume":"194","author":"Blanc","year":"2015","journal-title":"J. Immunol."},{"issue":"June (6)","key":"10.1016\/j.semcdb.2017.12.017_bib0210","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1172\/JCI68280","article-title":"C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation","volume":"123","author":"Tortajada","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.semcdb.2017.12.017_bib0215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \"Kidney Disease: Improving Global Outcomes\" (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.semcdb.2017.12.017_bib0220","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.semcdb.2017.12.017_bib0225","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1681\/ASN.2014101000","article-title":"Current understanding of the role of complement in IgA nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"March (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0230","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1167\/iovs.11-8709","article-title":"Spanish multicenter group on AMD. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration","volume":"53","author":"Mart\u00ednez-Barricarte","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.semcdb.2017.12.017_bib0235","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.4049\/jimmunol.1401613","article-title":"Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration","volume":"193","author":"Clark","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0240","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.molimm.2011.04.003","article-title":"Complement in the brain","volume":"48","author":"Veerhuis","year":"2011","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.semcdb.2017.12.017_bib0245","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1586\/1744666X.2015.1074039","article-title":"The role of complement in neurological and neuropsychiatric diseases","volume":"11","author":"Morgan","year":"2015","journal-title":"Exp. Rev. Clin. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-2094-8-4","article-title":"Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease","volume":"8","author":"Fonseca","year":"2011","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0255","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pneurobio.2003.08.001","article-title":"Yin and Yang: complement activation and regulation in Alzheimer's disease","volume":"70","author":"Shen","year":"2003","journal-title":"Prog. Neurobiol."},{"issue":"January (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0260","article-title":"Complement system in dermatological diseases - fire under the skin","volume":"2","author":"Panelius","year":"2015","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.semcdb.2017.12.017_bib0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu. Rev. Pathol."},{"issue":"3","key":"10.1016\/j.semcdb.2017.12.017_bib0270","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0275","first-page":"3","article-title":"Complement in skin diseases","volume":"20","author":"Kotnik","year":"2011","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0280","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrneph.2017.37","article-title":"Complement in ANCA-associated vasculitis: mechanisms and implications for management","volume":"13","author":"Chen","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0285","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000317194","article-title":"The harmful role of C5a in innate immunity in sepsis","volume":"2","author":"Ward","year":"2010","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0290","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00003246-198205000-00004","article-title":"Complement activation in septic shock due to gram-negative and gram-positive bacteria","volume":"10","author":"Le\u00f3n","year":"1982","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0295","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/clin.1993.1161","article-title":"Alterations in C3, C4, factor B, and related metabolites in septic shock","volume":"69","author":"Lin","year":"1993","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0300","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/infdis\/jiv074","article-title":"HIV coinfection enhances complement activation during sepsis","volume":"212","author":"Huson","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0305","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1128\/IAI.66.11.5350-5356.1998","article-title":"Complement activation in relation to capillary leakage in children with septic shock and purpura","volume":"66","author":"Hazelzet","year":"1998","journal-title":"Infect. Immun."},{"issue":"24","key":"10.1016\/j.semcdb.2017.12.017_bib0310","article-title":"Properdin levels in human sepsis","volume":"6","author":"Stover","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0315","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10875-005-4702-1","article-title":"Mannose binding lectin acute phase activity in patients with severe infection","volume":"25","author":"Dean","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0320","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.2734615","article-title":"Adipsin and complement factor D activity: an immune-related defect in obesity","volume":"244","author":"Rosen","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2017.12.017_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.1997.d01-890.x","article-title":"Extrahepatic complement biosynthesis: where, when and why?","volume":"107","author":"Morgan","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0330","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molimm.2008.09.013","article-title":"Dual role of complement in adipose tissue","volume":"46","author":"Pattrick","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0335","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2012.02.110","article-title":"A new effector of lipid metabolism: complement factor properdin","volume":"51","author":"Gauvreau","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0340","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/db09-0700","article-title":"Complement factor H is expressed in adipose tissue in association with insulin resistance","volume":"59","author":"Moreno-Navarrete","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.semcdb.2017.12.017_bib0345","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0350","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0355","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0360","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0365","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.177.6.1827","article-title":"Complement-mediated adipocyte lysis by nephritic factor sera","volume":"177","author":"Mathieson","year":"1993","journal-title":"J. Exp. Med."},{"issue":"September (16)","key":"10.1016\/j.semcdb.2017.12.017_bib0370","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1016\/j.molimm.2007.06.150","article-title":"Complement analysis in the 21st century","volume":"44","author":"Mollnes","year":"2007","journal-title":"Mol. Immunol."},{"issue":"April (4)","key":"10.1016\/j.semcdb.2017.12.017_bib0375","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","article-title":"Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers","volume":"143","author":"Yang","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"September (12)","key":"10.1016\/j.semcdb.2017.12.017_bib0380","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.addr.2011.05.010","article-title":"Advances in assay of complement function and activation","volume":"63","author":"Harboe","year":"2011","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"January (1)","key":"10.1016\/j.semcdb.2017.12.017_bib0385","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00467-013-2605-6","article-title":"C3 nephritic factor associated with C3 glomerulopathy in children","volume":"29","author":"Nicolas","year":"2014","journal-title":"Pediatr. Nephrol."},{"issue":"October (3\u20134)","key":"10.1016\/j.semcdb.2017.12.017_bib0390","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H autoantibodies in membranoproliferative glomerulonephritis","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol. Immunol."},{"issue":"September (10)","key":"10.1016\/j.semcdb.2017.12.017_bib0395","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"issue":"November (19)","key":"10.1016\/j.semcdb.2017.12.017_bib0400","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood"},{"issue":"November (11)","key":"10.1016\/j.semcdb.2017.12.017_bib0405","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00467-013-2560-2","article-title":"A novel hybrid CFHR1\/CFH gene causes atypical hemolytic uremic syndrome","volume":"28","author":"Eyler","year":"2013","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.semcdb.2017.12.017_bib0410","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol. Immunol."},{"issue":"February (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0415","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ki.1989.26","article-title":"Analysis of the complement C3 fragments associated with hemodialysis membranes","volume":"35","author":"Cheung","year":"1989","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.semcdb.2017.12.017_bib0420","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1423-0410.2011.01522.x","article-title":"Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma","volume":"102","author":"Norda","year":"2012","journal-title":"Vox Sang."},{"issue":"October (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0425","first-page":"63","article-title":"Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation","volume":"12","author":"Teisner","year":"1983","journal-title":"J. Clin. Lab Immunol."},{"issue":"December (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molimm.2013.05.221","article-title":"An international serum standard for application in assays to detect human complement activation products","volume":"56","author":"Bergseth","year":"2013","journal-title":"Mol. Immunol."},{"issue":"November (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0435","first-page":"251","article-title":"Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course","volume":"90","author":"Nilsson","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0440","series-title":"Weir\u2019s Handbook of Experimental Immunology","first-page":"75.1","article-title":"Purification, assay, characterisation of complement proteins from plasma","author":"Harrison","year":"1996"},{"key":"10.1016\/j.semcdb.2017.12.017_bib0445","series-title":"Experimental Immunochemistry","first-page":"133","article-title":"Complement and complement fixation","author":"Mayer","year":"1961"},{"key":"10.1016\/j.semcdb.2017.12.017_bib0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ajcp\/79.1.65","article-title":"A study of optimal reaction conditions for an assay of the human alternative complement pathway","volume":"79","author":"Joiner","year":"1983","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0455","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000467828","article-title":"Rapid homogeneous phase, liposome-based assays for total complement activity","volume":"1","author":"Akots","year":"1984","journal-title":"Complement"},{"key":"10.1016\/j.semcdb.2017.12.017_bib0460","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jim.2004.11.016","article-title":"Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA","volume":"296","author":"Seelen","year":"2005","journal-title":"J. Immunol. Methods"},{"issue":"May (1)","key":"10.1016\/j.semcdb.2017.12.017_bib0465","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molimm.2004.01.003","article-title":"Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H","volume":"41","author":"S\u00e1nchez-Corral","year":"2004","journal-title":"Mol. Immunol."},{"issue":"December (6)","key":"10.1016\/j.semcdb.2017.12.017_bib0470","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-3083.1997.d01-168.x","article-title":"A neoepitope-based enzyme immunoassay for quantification of C1-inhibitor in complex with C1r and C1s","volume":"46","author":"Fure","year":"1997","journal-title":"Scand. J. Immunol."},{"issue":"September (9)","key":"10.1016\/j.semcdb.2017.12.017_bib0475","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12657","article-title":"C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay","volume":"70","author":"Ghannam","year":"2015","journal-title":"Allergy"},{"issue":"September (3)","key":"10.1016\/j.semcdb.2017.12.017_bib0480","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jaci.2004.06.044","article-title":"International union of immunological societies primary immunodeficiency diseases classification committee. Primary immunodeficiency diseases: an update","volume":"114","author":"Notarangelo","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"August","key":"10.1016\/j.semcdb.2017.12.017_bib0485","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jim.2016.05.009","article-title":"Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab","volume":"435","author":"Riedl","year":"2016","journal-title":"J. Immunol. Methods"},{"issue":"October (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0490","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clim.2015.05.018","article-title":"Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome","volume":"160","author":"Volokhina","year":"2015","journal-title":"Clin. Immunol."},{"issue":"October (4)","key":"10.1016\/j.semcdb.2017.12.017_bib0495","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/cpt.686","article-title":"Eculizumab dosing regimen in atypical HUS: possibilities for individualized","volume":"102","author":"Volokhina","year":"2017","journal-title":"Treat. Clin. Pharmacol. Ther."},{"issue":"September","key":"10.1016\/j.semcdb.2017.12.017_bib0500","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2017.05.013","article-title":"Complement in clinical medicine: Clinical trials, case reports and therapy monitoring","volume":"89","author":"Ricklin","year":"2017","journal-title":"Mol. Immunol."},{"issue":"September (9)","key":"10.1016\/j.semcdb.2017.12.017_bib0505","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jth.12615","article-title":"Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome","volume":"12","author":"Cugno","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"January (1)","key":"10.1016\/j.semcdb.2017.12.017_bib0510","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"HUS international. An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr. Nephrol."},{"issue":"February (2)","key":"10.1016\/j.semcdb.2017.12.017_bib0515","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cei.12890","article-title":"Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders","volume":"187","author":"Wehling","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.semcdb.2017.12.017_bib0520","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2014.07.004","article-title":"Complement nomenclature","volume":"61","author":"Kemper","year":"2014","journal-title":"Mol. Immunol."}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952117301465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952117301465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T15:16:17Z","timestamp":1603638977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952117301465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":104,"alternative-id":["S1084952117301465"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2017.12.017","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement as a diagnostic tool in immunopathology","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cell & Developmental Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcdb.2017.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}